These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 793856)

  • 21. Oral pulsatile delivery: rationale and chronopharmaceutical formulations.
    Maroni A; Zema L; Del Curto MD; Loreti G; Gazzaniga A
    Int J Pharm; 2010 Oct; 398(1-2):1-8. PubMed ID: 20655998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oral dosage forms with sustained release].
    Boer Y
    Pharm Weekbl; 1973 Feb; 108(6):109-20. PubMed ID: 4699091
    [No Abstract]   [Full Text] [Related]  

  • 24. [Influence of various factors on the velocity of drug release from depot tablets. 2. Isoniazid-depot tablets].
    Naplatanova D; Tomassini L
    Pharmazie; 1974 May; 29(5):321-3. PubMed ID: 4848951
    [No Abstract]   [Full Text] [Related]  

  • 25. [Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard].
    Chalabala M; Starha L
    Cesk Farm; 1970 Jun; 19(5):184-6. PubMed ID: 5448541
    [No Abstract]   [Full Text] [Related]  

  • 26. [The classification and serial coding of drugs].
    Aronson PIu; Kagan MI; Sviatynia MI
    Med Prom SSSR; 1966 Aug; 20(8):13-6. PubMed ID: 6001860
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: The line-up on bioavailability.
    Schneller GH
    Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
    [No Abstract]   [Full Text] [Related]  

  • 28. [Progress in pharmaceutical technology during 1970 and 1971].
    Chalabala M; Heliová M; Lichnerová I; Rak J; Malý J; Slaný J; Starha J
    Cesk Farm; 1972 Nov; 21(9):411-31. PubMed ID: 4575871
    [No Abstract]   [Full Text] [Related]  

  • 29. [Tablets in stool? A common problem!].
    Schuerch LV; Nyfeler J; Holder G; Surber C; Haefeli WE
    Schweiz Med Wochenschr; 1999 May; 129(17):670-3. PubMed ID: 10407938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug dosage form and action].
    Zathurecký L
    Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of drug release from pellets coated with different shellac types.
    Farag Y; Leopold CS
    Drug Dev Ind Pharm; 2011 Feb; 37(2):193-200. PubMed ID: 21073321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Crug formulation and liberation of the active ingredient in of chloroquine phosphate].
    Gyarmati L; Stampf G; Morzsányi E; Soós G; Nagy E; Ablonczy E
    Acta Pharm Hung; 1975 Jul; 45(4):155-9. PubMed ID: 1096532
    [No Abstract]   [Full Text] [Related]  

  • 36. Disintegration of coated tablets -- unit-to-unit variation.
    Sandell E; Mellström G
    Acta Pharm Suec; 1975; 12(3):293-6. PubMed ID: 1163249
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lacquered tablets and film dragees].
    Hess H; Janssen HJ
    Pharm Acta Helv; 1969 Oct; 44(10):581-601. PubMed ID: 4901296
    [No Abstract]   [Full Text] [Related]  

  • 39. Dosage form and the physiologic availability of drugs.
    Middleton EJ
    Med Times; 1967 Apr; 95(4):385-90. PubMed ID: 6021603
    [No Abstract]   [Full Text] [Related]  

  • 40. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.